Certified by Founder Lodge
Cure51
France - Paris
START UP
1 Disclosed Funding Rounds $16,260,975
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 20 ,2024 | Seed | $16,260,975 |
Life Extension Ventures
Hitachi Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Stratus Medical | $10,000,000 | (Feb 5, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
